These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 21054129)
21. Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light. Yu G; Durduran T; Zhou C; Zhu TC; Finlay JC; Busch TM; Malkowicz SB; Hahn SM; Yodh AG Photochem Photobiol; 2006; 82(5):1279-84. PubMed ID: 16696593 [TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy for focal ablation of the prostate. Arumainayagam N; Moore CM; Ahmed HU; Emberton M World J Urol; 2010 Oct; 28(5):571-6. PubMed ID: 20454966 [TBL] [Abstract][Full Text] [Related]
23. Revisiting photodynamic therapy dosimetry: reductionist & surrogate approaches to facilitate clinical success. Pogue BW; Elliott JT; Kanick SC; Davis SC; Samkoe KS; Maytin EV; Pereira SP; Hasan T Phys Med Biol; 2016 Apr; 61(7):R57-89. PubMed ID: 26961864 [TBL] [Abstract][Full Text] [Related]
24. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. Azzouzi AR; Vincendeau S; Barret E; Cicco A; Kleinclauss F; van der Poel HG; Stief CG; Rassweiler J; Salomon G; Solsona E; Alcaraz A; Tammela TT; Rosario DJ; Gomez-Veiga F; Ahlgren G; Benzaghou F; Gaillac B; Amzal B; Debruyne FM; Fromont G; Gratzke C; Emberton M; Lancet Oncol; 2017 Feb; 18(2):181-191. PubMed ID: 28007457 [TBL] [Abstract][Full Text] [Related]
26. Monte Carlo modelling of angular radiance in tissue phantoms and human prostate: PDT light dosimetry. Barajas O; Ballangrud AM; Miller GG; Moore RB; Tulip J Phys Med Biol; 1997 Sep; 42(9):1675-87. PubMed ID: 9308075 [TBL] [Abstract][Full Text] [Related]
27. Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy. Jankun J; Keck RW; Skrzypczak-Jankun E; Lilge L; Selman SH BJU Int; 2005 Jun; 95(9):1237-44. PubMed ID: 15892808 [TBL] [Abstract][Full Text] [Related]
28. Feasibility of interstitial diffuse optical tomography using cylindrical diffusing fibers for prostate PDT. Liang X; Wang KK; Zhu TC Phys Med Biol; 2013 May; 58(10):3461-80. PubMed ID: 23629149 [TBL] [Abstract][Full Text] [Related]
29. Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate. Xiao Z; Owen RJ; Liu W; Tulip J; Brown K; Woo T; Moore RB Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):106-14. PubMed ID: 20510305 [TBL] [Abstract][Full Text] [Related]
31. Transperineal in vivo fluence-rate dosimetry in the canine prostate during SnET2-mediated PDT. Lilge L; Pomerleau-Dalcourt N; Douplik A; Selman SH; Keck RW; Szkudlarek M; Pestka M; Jankun J Phys Med Biol; 2004 Jul; 49(14):3209-25. PubMed ID: 15357193 [TBL] [Abstract][Full Text] [Related]
32. Vascular targeted photodynamic therapy with TOOKAD® Soluble (WST11) in localized prostate cancer: efficiency of automatic pre-treatment planning. Betrouni N; Boukris S; Benzaghou F Lasers Med Sci; 2017 Aug; 32(6):1301-1307. PubMed ID: 28569345 [TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Baas P; Murrer L; Zoetmulder FA; Stewart FA; Ris HB; van Zandwijk N; Peterse JL; Rutgers EJ Br J Cancer; 1997; 76(6):819-26. PubMed ID: 9310252 [TBL] [Abstract][Full Text] [Related]
34. An image guided treatment platform for prostate cancer photodynamic therapy. Betrouni N; Colin P; Puech P; Villers A; Mordon S Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():370-3. PubMed ID: 24109701 [TBL] [Abstract][Full Text] [Related]
35. Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC. Hornung R; Fehr MK; Monti-Frayne J; Tromberg BJ; Berns MW; Tadir Y Br J Cancer; 1999 Oct; 81(4):631-7. PubMed ID: 10574248 [TBL] [Abstract][Full Text] [Related]
36. Fractionated versus standard continuous light delivery in interstitial photodynamic therapy of dunning prostate carcinomas. Xiao Z; Halls S; Dickey D; Tulip J; Moore RB Clin Cancer Res; 2007 Dec; 13(24):7496-505. PubMed ID: 18094434 [TBL] [Abstract][Full Text] [Related]
37. Feasibility of interstitial Doppler optical coherence tomography for in vivo detection of microvascular changes during photodynamic therapy. Li H; Standish BA; Mariampillai A; Munce NR; Mao Y; Chiu S; Marcon NE; Wilson BC; Vitkin A; Yang VX Lasers Surg Med; 2006 Sep; 38(8):754-61. PubMed ID: 16927368 [TBL] [Abstract][Full Text] [Related]
38. Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. Chen Q; Wilson BC; Shetty SD; Patterson MS; Cerny JC; Hetzel FW Radiat Res; 1997 Jan; 147(1):86-91. PubMed ID: 8989374 [TBL] [Abstract][Full Text] [Related]
39. Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy. Moore CM; Azzouzi AR; Barret E; Villers A; Muir GH; Barber NJ; Bott S; Trachtenberg J; Arumainayagam N; Gaillac B; Allen C; Schertz A; Emberton M BJU Int; 2015 Dec; 116(6):888-96. PubMed ID: 24841929 [TBL] [Abstract][Full Text] [Related]
40. Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: phantom and volunteer experiments. Nyst HJ; van Veen RL; Tan IB; Peters R; Spaniol S; Robinson DJ; Stewart FA; Levendag PC; Sterenborg HJ Lasers Surg Med; 2007 Sep; 39(8):647-53. PubMed ID: 17886277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]